A leadership and advisory team of rare depth
An experienced core leadership team is in place and fully committed to Innervate, supported by world-leading neurologists, neuroscientists and the global authority on GDNF structure and function.
Management team
Prof. Steven Gill
Chief Scientific OfficerHonorary Professor of Neurosurgery at the University of Bristol and a retired Consultant Neurosurgeon at Southmead Hospital, Bristol.
Mike Davies
Chief Technical OfficerTechnical operations specialist with 25+ years of commercial experience in early and late-stage biologics development across CDMO and biopharma.
Prof. Neil Barua
Consultant NeurosurgeonNeuro-oncology surgeon with over 15 years’ experience of pre-clinical and clinical convection-enhanced delivery (CED) research.
Keith Murdoch
Life Sciences AdvisorExtensive knowledge of the life sciences sector through work with numerous CROs across the UK and US, as both a director and an advisor.
Scientific & clinical advisory
Prof. Kevin Talbot
Professor of Motor Neurone Biology, OxfordWorld-renowned Consultant Neurologist and Head of Department at Oxford’s Nuffield Department of Clinical Neurosciences.
Prof. Martin Turner
Professor of Clinical Neurology, OxfordConsultant Neurologist to the John Radcliffe Hospital and Chair of the Research Committee of the Association of British Neurologists.
Prof. Mart Saarma
Professor emeritus, University of HelsinkiInternationally acclaimed neurotrophin expert who discovered the GDNF receptors and elucidated the GDNF–GFRα1 receptor complex.